课题基金 / 基金详情

SynthSys-Mammalian: Edinburgh Mammalian Synthetic Biology Research Centre

SynthSys-Mammalian: Edinburgh Mammalian Synthetic Biology Research Centre
SynthSys-Mammalian:爱丁堡哺乳动物合成生物学研究中心
批准号:
BB/M018040/1
负责人:
Susan Rosser
金额:
$1600.1万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2014
资助国家:
英国
项目状态:
已结题
起止时间:
2014 至 --

项目摘要

项目成果

Susan Rosser的其他基金

相似基金

相关文献

中文摘要
翻译
爱丁堡哺乳动物合成生物学中心(synthsys -哺乳动物)的愿景是开拓实施工程原理所需的基础工具和技术的发展,并在哺乳动物系统中实现合成生物学的全部潜力。我们有一个雄心勃勃的计划,在细胞工程工具生成、全细胞建模、计算机辅助设计和DNA构建以及高通量表型方面建立内部专业知识,使合成生物学在哺乳动物系统中的多种应用成为可能。通过这种方式,我们不仅将推进对哺乳动物生物学的基本理解,而且还将为制药和药物测试行业、用于诊断的生物传感细胞系、新疗法、基于蛋白质的药物(如抗体)的生产以及用于再生医学应用的干细胞发育和分化编程等领域的近期商业开发提供工具和技术。与此同时,我们将发展和实施对这一影响深远的技术的社会和经济影响的新认识,以确保其造福社会。
英文摘要
The vision for Edinburgh's Centre for Mammalian Synthetic Biology (SynthSys-Mammalian) is to pioneer the development of the underpinning tools and technologies needed to implement engineering principles and realise the full potential of synthetic biology in mammalian systems. We have an ambitious plan to build in-house expertise in cell engineering tool generation, whole-cell modelling, computer-assisted design and construction of DNA and high-throughput phenotyping to enable synthetic biology in mammalian systems for multiple applications. In this way we will not only advance basic understanding of mammalian biology but also generate tools and technologies for near-term commercial exploitation in areas such as the pharmaceutical and drug testing industries, biosensing cell lines sensing disease biomarkers for diagnositics, novel therapeutics, production of protein based drugs e.g. antibodies and also programming stem cell development and differentiation for regenerative medicine applications. In parallel we will develop and implement new understanding of the social and economic impact of this far-reaching technology to ensure its benefits to society.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Genetic Constructor: An Online DNA Design Platform.
Genetic Constructor:在线 DNA 设计平台。
DOI: 10.1021/acssynbio.7b00236
发表时间: 2017
期刊: ACS synthetic biology
影响因子: 4.7
作者: [Bates M]
通讯作者: Bates M
DOI: 10.1080/09537325.2019.1685087
发表时间: 2019-11
期刊: Technology Analysis & Strategic Management
影响因子: 3.4
作者: [Geoffrey Banda;James Mittra;J. Tait;Andrew Watkins;O. Omidvar]
通讯作者: Geoffrey Banda;James Mittra;J. Tait;Andrew Watkins;O. Omidvar
DOI: 10.1038/s41598-018-32929-7
发表时间: 2018-10-09
期刊: Scientific reports
影响因子: 4.6
作者: [Baaske J, Gonschorek P, Engesser R, Dominguez-Monedero A, Raute K, Fischbach P, Müller K, Cachat E, Schamel WWA, Minguet S, Davies JA, Timmer J, Weber W, Zurbriggen MD]
通讯作者: Zurbriggen MD
Taking Roles in Interdisciplinary Collaborations: Reflections on working in Post-ELSI Spaces in the UK Synthetic Biology Community
在跨学科合作中发挥作用:对英国合成生物学界后 ELSI 空间工作的反思
DOI: --
发表时间: 2015
期刊: Science and Technology Studies
影响因子: 1.2
作者: [Balmer, A]
通讯作者: Balmer, A
Engineered Genetic Control Systems for Advanced Therapeutics
  • 批准号:
    BB/Y008545/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $1575.86万
  • 财政年份:
    2024
  • 负责人:
    Susan Rosser
  • 依托单位:
21ENGBIO Controllable DNA polycatenanes of infinite length for intelligent biomaterials
  • 批准号:
    BB/W01338X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $12.85万
  • 财政年份:
    2022
  • 负责人:
    Susan Rosser
  • 依托单位:
21EBTA Engineering Biology for Cell and Gene Therapy Applications
  • 批准号:
    BB/W014610/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $193.46万
  • 财政年份:
    2022
  • 负责人:
    Susan Rosser
  • 依托单位:
Optimisation of CHO for Biotherapeutic Manufacture
  • 批准号:
    EP/V038095/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $472.6万
  • 财政年份:
    2021
  • 负责人:
    Susan Rosser
  • 依托单位:
海外基金